D. Gastfriend

发表

Acute Effects of Cocaine on Human Brain Activity and Emotion

S. Hyman, H. Breiter, J. Berke, 1997, Neuron.

Cocaine Decreases Cortical Cerebral Blood Flow but Does Not Obscure Regional Activation in Functional Magnetic Resonance Imaging in Human Subjects

S. Hyman, H. Breiter, A. Guimarães, 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Nitric oxide-induced motor neuron disease in a patient with alcoholism.

D. Gastfriend, G. Tsai, 1995, The New England journal of medicine.

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

David Couper, Allen Zweben, Richard Longabaugh, 2006, JAMA.

The effect of 12-step self-help group attendance and participation on drug use outcomes among cocaine-dependent patients.

R. Gallop, M. Thase, D. Gastfriend, 2005, Drug and alcohol dependence.

Cocaine dependence with and without PTSD among subjects in the National Institute on Drug Abuse Collaborative Cocaine Treatment Study.

M. Thase, D. Gastfriend, R. Weiss, 1998, The American journal of psychiatry.

Predictors of self-help group attendance in cocaine dependent patients.

R. Gallop, D. Gastfriend, L. Onken, 2000, Journal of studies on alcohol.

The ASAM Patient Placement Criteria

D. Gastfriend, D. Mee-Lee, 2004, Journal of addictive diseases.

Predictive Validity of the ASAM Patient Placement Criteria for Hospital Utilization

D. Gastfriend, W. Penk, E. Sharon, 2004, Journal of addictive diseases.

The National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Rationale and methods.

M. Thase, A. Beck, G. Woody, 1997, Archives of general psychiatry.

Establishing the feasibility of performance measures for alcohol and other drugs.

D. Gastfriend, C. Horgan, D. Garnick, 2002, Journal of substance abuse treatment.

Reduction in heavy drinking as a treatment outcome in alcohol dependence.

D. Gastfriend, R. Forman, H. Pettinati, 2007, Journal of substance abuse treatment.

Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol DependenceA Randomized Controlled Trial

H. Kranzler, D. Gastfriend, H. Pettinati, 2005 .

Factorial designs in clinical trials: options for combination treatment studies.

D. Couper, D. Kivlahan, J. Hosking, 2005, Journal of studies on alcohol. Supplement.

The Severity Index

D. Gastfriend, Lee Panas, Y. Caspi, 2001 .

A Multi-site Dose Ranging Study of Nalmefene in the Treatment of Alcohol Dependence

H. Kranzler, D. Gastfriend, A. Zweben, 2004, Journal of clinical psychopharmacology.

The Relationship Between Cocaine Craving, Psychosocial Treatment, and Subsequent Cocaine Use

D. Gastfriend, R. Weiss, J. Blaine, 2003 .

The relationship between cocaine craving, psychosocial treatment, and subsequent cocaine use.

D. Gastfriend, R. Weiss, J. Blaine, 2000, The American journal of psychiatry.

Efficacy of Extended-Release Naltrexone in Alcohol-Dependent Patients Who Are Abstinent Before Treatment

H. Kranzler, D. Gastfriend, S. O'Malley, 2007, Journal of clinical psychopharmacology.

Patient placement criteria and their relation to access to appropriate level of care and engagement in alcoholism treatment.

D. Gastfriend, A. Rubin, Amy Rubin, 2001, Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism.

Treating Opioid Dependence With Injectable Extended-Release Naltrexone (XR-NTX)

E. Nunes, W. Ling, D. Gastfriend, 2015, Journal of addiction medicine.

Who starts treatment: engagement in the NIDA collaborative cocaine treatment study.

D. Gastfriend, J. Blaine, P. Crits-Christoph, 2002, The American journal on addictions.

Naltrexone Treatment for Alcohol Dependency—Reply

H. Kranzler, D. Gastfriend, H. Pettinati, 2005 .

Regular article Establishing the feasibility of performance measures for alcohol and other drugs

D. Gastfriend, C. Horgan, D. Garnick, 2002 .

Ultrarapid opioid detoxification: effects on cardiopulmonary physiology, stress hormones and clinical outcomes.

H. Breiter, D. Gastfriend, I. Elman, 2001, Drug and alcohol dependence.

A pilot study of factors associated with resilience to substance abuse in adolescent sons of alcoholic fathers.

D. Gastfriend, S. Springer, 1995, Journal of addictive diseases.

Treatment matching. Theoretic basis and practical implications.

D. Gastfriend, A. Mclellan, A. Thomas McLellan, 1997, The Medical clinics of North America.

Thirty Years of TheASAMCriteria: A Report Card.

D. Gastfriend, D. Mee-Lee, 2022, The Psychiatric clinics of North America.

Predictive and convergent validity of the ASAM criteria software in Norway

D. Gastfriend, Marianne Stallvik, 2014 .

No-Show for Treatment in Substance Abuse Patients with Comorbid Symptomatology: Validity Results from a Controlled Trial of the ASAM Patient Placement Criteria

D. Gastfriend, G. Angarita, S. Reif, 2007, Journal of addiction medicine.

Determining Service Variations Between and Within ASAM Levels of Care

D. Gastfriend, S. Reif, W. Turner, 2004, Journal of addictive diseases.

SUBSTANCE USER TREATMENT PROGRAM QUALITY: SELECTED TOPICS

D. Gastfriend, A. Rosenblum, S. Magura, 2002, Substance use & misuse.

Integrating Addiction Medicine With Psychiatry: Clinical Collaboration and Resource Parity

D. Gastfriend, M. Rorro, 2001 .

Psychosocial Treatments For Cocaine Dependence: Results Of The National Institute On Drug Abuse Collaborative Cocaine Treatment Study

M. Thase, G. Woody, D. Gastfriend, 1999 .

Cardiovascular effects of desipramine in children and adolescents with attention deficit disorder.

J. Biederman, D. Gastfriend, M. Jellinek, 1985, The Journal of pediatrics.

Desipramine in the treatment of children with attention deficit disorder.

J. Biederman, D. Gastfriend, M. Jellinek, 1986, Journal of clinical psychopharmacology.

Desipramine in the treatment of attention deficit disorder in adolescents.

J. Biederman, D. Gastfriend, M. Jellinek, 1985, Psychopharmacology bulletin.

Effects of injectable extended-release naltrexone (XR-NTX) for opioid dependence on residential rehabilitation outcomes and early follow-up.

E. Bixler, D. Gastfriend, R. Meyer, 2015, The American journal on addictions.

Prevalence of physical and sexual abuse among substance abuse patients and impact on treatment outcomes.

D. Gastfriend, G. Angarita, E. Sharon, 2005, Drug and alcohol dependence.

Clinical outcomes following cocaine infusion in nontreatment-seeking individuals with cocaine dependence

H. Breiter, R. Gollub, D. Schoenfeld, 2001, Biological Psychiatry.

The Addiction Severity Index as a screen for trauma and posttraumatic stress disorder.

M. Thase, D. Gastfriend, S. Butler, 1998, Journal of studies on alcohol.

A Measure of Readiness for Substance Abuse Treatment

M. Thase, D. Gastfriend, J. Blaine, 1997 .

Decreased Absolute Amygdala Volume in Cocaine Addicts

Matthew D. Albaugh, David A. Ziegler, S. Hyman, 2004, Neuron.

Practical Technology for Expanding and Improving Substance Use Disorder Treatment

August F. Holtyn, M. Stitzer, D. Gastfriend, 2022, The Psychiatric clinics of North America.

Olanzapine-induced hyperventilation: case report.

D. Gastfriend, S. Sattar, 2002, Journal of psychiatry & neuroscience : JPN.

Injectable extended-release naltrexone for opioid dependence

E. Nunes, W. Ling, D. Gastfriend, 2011, The Lancet.

Open-label Study of Injectable Extended-release Naltrexone (XR-NTX) in Healthcare Professionals With Opioid Dependence

D. Gastfriend, B. Silverman, J. Zummo, 2017, Journal of addiction medicine.

Use of haloperidol in the management of agitated or violent, alcohol-intoxicated patients in the emergency department: a pilot study.

D. Gastfriend, G. Lenehan, C. Stetler, 1985, Journal of emergency nursing: JEN : official publication of the Emergency Department Nurses Association.

A Voice-Based Computer Interview for Drug Dependence

L. Baer, D. Gastfriend, S. Gitlow, 1996 .

Depressive symptomatology and cocaine-induced pituitary-adrenal axis activation in individuals with cocaine dependence.

H. Breiter, R. Gollub, H. Kantor, 1999, Drug and alcohol dependence.

Developing a baseline assessment battery: balancing patient time burden with essential clinical and research monitoring.

D. Gastfriend, D. Donovan, Kelly T Murray, 2005, Journal of studies on alcohol. Supplement.

The glutamatergic basis of human alcoholism.

J. Coyle, D. Gastfriend, G. Tsai, 1995, The American journal of psychiatry.

Comorbidity, Smoking Behavior and Treatment Outcome

D. Abrams, R. Niaura, M. Goldstein, 2000, Psychotherapy and Psychosomatics.

Overriding the blockade of antinociceptive actions of opioids in rats treated with extended-release naltrexone

M. Todtenkopf, D. Gastfriend, D. Deaver, 2008, Pharmacology Biochemistry and Behavior.

Buprenorphine Treatment of Opiate and Cocaine Abuse: Clinical and Preclinical Studies

David R. Gastfriend, Jack H. Mendelson, Scott E. Lukas, 1993, Harvard review of psychiatry.

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial.

H. Kranzler, D. Gastfriend, H. Pettinati, 2005, JAMA.

Buprenorphine pharmacotherapy for concurrent heroin and cocaine dependence.

J. Mendelson, N. Mello, D. Gastfriend, 1993 .

Validation of the Addiction Severity Index (ASI) for internet and automated telephone self-report administration.

C. Rosen, D. Gastfriend, B. Brodey, 2004, Journal of substance abuse treatment.

The Addiction Severity Index: a field study of internal consistency and validity.

D. Gastfriend, M. Shwartz, K. Mulvey, 2000, Journal of substance abuse treatment.

Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: dose-effects and time-course.

K. Preston, G. Bigelow, D. Gastfriend, 2012, Drug and alcohol dependence.

Extended-Release Naltrexone for Alcohol and Opioid Problems in Missouri Parolees and Probationers.

R. Gallop, D. Gastfriend, P. Crits-Christoph, 2015, Journal of Substance Abuse Treatment.

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial

E. Nunes, W. Ling, D. Gastfriend, 2011, The Lancet.

Intramuscular extended‐release naltrexone: current evidence

D. Gastfriend, 2011, Annals of the New York Academy of Sciences.

Cost and utilization outcomes of opioid-dependence treatments.

D. Gastfriend, O. Baser, D. Fiellin, 2011, The American journal of managed care.

The validity of self-reported drug use in non-treatment seeking individuals with cocaine dependence: correlation with biochemical assays.

H. Breiter, R. Gollub, D. Gastfriend, 2000, The American journal on addictions.

Matching patients with substance use disorder to optimal level of care with the ASAM Criteria software

D. Gastfriend, H. Nordahl, Marianne Stallvik, 2015 .

Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study.

L R Muenz, L Luborsky, M. Thase, 1999, Archives of general psychiatry.

Annals of the New York Academy of Sciences a Pharmaceutical Industry Perspective on the Economics of Treatments for Alcohol and Opioid Use Disorders

D. Gastfriend, Sci, A. N. Acad, 2022 .

Comparison of healthcare utilization among patients treated with alcoholism medications.

T. Mark, H. Kranzler, D. Gastfriend, 2010, The American journal of managed care.

Design and analysis of trials of combination therapies.

D. Couper, D. Kivlahan, J. Hosking, 2005, Journal of studies on alcohol. Supplement.

Physician substance abuse and recovery: what does it mean for physicians--and everyone else?

D. Gastfriend, 2005, JAMA.

Rapid opioid detoxification.

D. Gastfriend, C. Brewer, 1998, JAMA.

Postcardiotomy delirium: a critical review.

D. Gastfriend, W. Dubin, H. Field, 1979, The Journal of thoracic and cardiovascular surgery.

The effect of anonymous vs. nonanonymous rating conditions on patient satisfaction and motivation ratings in a population of substance abuse patients.

D. Gastfriend, A. Plough, J. Neill, 1997, Alcoholism, clinical and experimental research.

Attitudes and practices on the use of extended-release naltrexone in criminal justice settings

D. Festinger, K. Dugosh, D. Gastfriend, 2017 .

Adjunct low dose lithium carbonate in treatment-resistant depression: a placebo-controlled study.

J. Rosenbaum, J. Biederman, D. Gastfriend, 1988, Journal of clinical psychopharmacology.

15 – Drug-Addicted Patients

D. Gastfriend, J. Renner, J. D. Ross, 2010 .

Self-help group attendance and participation among cocaine dependent patients.

R. Gallop, D. Gastfriend, L. Onken, 2000, Drug and alcohol dependence.

Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.

D. Gastfriend, R. Forman, H. Pettinati, 2011, Alcoholism, clinical and experimental research.

Effect of extended-release naltrexone (XR-NTX) on quality of life in alcohol-dependent patients.

H. Kranzler, D. Gastfriend, H. Pettinati, 2009, Alcoholism, clinical and experimental research.

Extended-release naltrexone for alcohol and opioid dependence: a meta-analysis of healthcare utilization studies.

Daniel M. Hartung, D. Gastfriend, D. McCarty, 2014, Journal of substance abuse treatment.

New Constructs and Assessments for Relapse and Continued Use Potential in the ASAM Patient Placement Criteria

G. Marlatt, D. Gastfriend, R. Anton, 2004, Journal of addictive diseases.

The Protocol Deviation Patient: Characterization and Implications for Clinical Trials Research

M. Thase, D. Gastfriend, J. Blaine, 1998 .

Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness.

E. Nunes, W. Ling, D. Gastfriend, 2013, Addiction.

Validity of Assessing Treatmen Readiness in Patients With Substance Use Disorders

D. Gastfriend, L. Najavits, W. Filstead, 1995 .

HIV risk reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study.

R. Gallop, G. Woody, D. Gastfriend, 2003, Journal of acquired immune deficiency syndromes.

Reliability of Multidimensional Substance Abuse Treatment Matching

D. Gastfriend, Sharon Baker, 2004, Journal of addictive diseases.

Feasibility of multidimensional substance abuse treatment matching: automating the ASAM Patient Placement Criteria. American Society of Addiction Medicine.

W. Gutowski, D. Gastfriend, S. Reif, 1999, Drug and alcohol dependence.

Persistence with oral naltrexone for alcohol treatment: implications for health-care utilization.

J. Stephenson, H. Kranzler, D. Gastfriend, 2008, Addiction.

Addiction denial and cognitive dysfunction: a preliminary investigation.

W. Rinn, D. Gastfriend, Nitigna Desai, 2002, The Journal of neuropsychiatry and clinical neurosciences.

Retention in psychosocial treatment of cocaine dependence: predictors and impact on outcome.

M. Gladis, R. Gallop, M. Thase, 2002, The American journal on addictions.

Impact of psychosocial treatments on associated problems of cocaine-dependent patients.

M. Thase, D. Gastfriend, R. Weiss, 2001, Journal of consulting and clinical psychology.

Placement Matching: Challenges and Technical Progress

D. Gastfriend, E. Sharon, Shaohua Lu, 2000, Substance use & misuse.

Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods.

D. Gastfriend, 2003, Alcoholism, clinical and experimental research.

Physician Substance Abuse—Reply

D. Gastfriend, 2005 .

Advancing performance measures for use of medications in substance abuse treatment.

Alex H. S. Harris, T. Mark, D. Gastfriend, 2011, Journal of substance abuse treatment.

[Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomized trial].

E. Nunes, W. Ling, D. Gastfriend, 2012, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

Long-term opioid blockade and hedonic response: preliminary data from two open-label extension studies with extended-release naltrexone.

D. Gastfriend, C. O'brien, R. Forman, 2010, The American journal on addictions.

Desipramine in the treatment of adolescents with attention deficit disorder.

J. Biederman, D. Gastfriend, M. Jellinek, 1984, The American journal of psychiatry.

Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder.

J. Rosenbaum, D. Gastfriend, 1989, The American journal of psychiatry.

A Naturalistic Evaluation of Extended-Release Naltrexone in Clinical Practice in Missouri.

R. Gallop, D. Gastfriend, P. Crits-Christoph, 2016, Journal of substance abuse treatment.

Chapter 16 – Alcoholic Patients—Acute and Chronic

D. Gastfriend, J. Renner, T. Hackett, 2004 .

An Intelligent Display System for psychiatric education in primary care.

P. Politser, D. Gastfriend, D R Gastfriend, 1987, Medical care.

Buprenorphine effects on morphine- and cocaine-induced subjective responses by drug-dependent men.

J. Mendelson, N. Mello, D. Gastfriend, 1994, Journal of clinical psychopharmacology.

Cocaine-primed craving and its relationship to depressive symptomatology in individuals with cocaine dependence

C. Chabris, H. Breiter, D. Gastfriend, 2002, Journal of psychopharmacology.

Voice Interactive Computers for Attitudinal Interviewing

Stuart Gitlow, David R. Gastfriend, D. Gastfriend, 1996 .

Effects of naltrexone treatment for alcohol-related disorders on healthcare costs in an insured population.

J. Stephenson, H. Kranzler, D. Gastfriend, 2010, Alcoholism, clinical and experimental research.

Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.

D. Gastfriend, O. Baser, M. Chalk, 2011, American Journal of Managed Care.

Developing performance measures for alcohol and other drug services in managed care plans. Washington Circle Group.

D. Gastfriend, P. A. Harrison, F. Cotter, 2000, The Joint Commission journal on quality improvement.

GENDER DIFFERENCES IN COCAINE CRAVING AMONG NON-TREATMENT-SEEKING INDIVIDUALS WITH COCAINE DEPENDENCE

D. Gastfriend, I. Elman, Katherine H. Karlsgodt, 2001, The American journal of drug and alcohol abuse.

Predicting Addiction Severity Index (ASI) Interviewer Severity Ratings for a computer-administered ASI

F. L. Newman, D. Gastfriend, S. Butler, 1998 .

BRIEF REPORTS Impact of Psychosocial Treatments on Associated Problems of Cocaine-Depen dent Patients

M. Thase, D. Gastfriend, R. Weiss, 2001 .

Advances in the pharmacotherapy of alcoholism: challenging misconceptions.

H. Kranzler, D. Gastfriend, M. Willenbring, 2006, Alcoholism, clinical and experimental research.

Early treatment response in alcohol dependence with extended-release naltrexone.

D. Ciraulo, D. Gastfriend, H. Pettinati, 2008, The Journal of clinical psychiatry.

Orthostatic hypotension and antidepressant pharmacotherapy.

J. Rosenbaum, J. Biederman, M. Pollack, 1987, Psychopharmacology bulletin.

Activation of human brain reward circuitry by cocaine observed using FMRI

S. Hyman, H. Breiter, J. Berke, 1996 .